Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Novartis
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01633112
First received: June 29, 2012
Last updated: August 3, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2022
  Estimated Primary Completion Date: March 2022 (Final data collection date for primary outcome measure)